1-(2,6-dichlorophenyl)-4-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline

ID: ALA1278130

Cas Number: 343372-37-2

PubChem CID: 3848696

Max Phase: Preclinical

Molecular Formula: C16H7Cl2F3N4

Molecular Weight: 383.16

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  FC(F)(F)c1nc2ccccc2n2c(-c3c(Cl)cccc3Cl)nnc12

Standard InChI:  InChI=1S/C16H7Cl2F3N4/c17-8-4-3-5-9(18)12(8)14-23-24-15-13(16(19,20)21)22-10-6-1-2-7-11(10)25(14)15/h1-7H

Standard InChI Key:  WTRRGKLODXSCQG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   26.7337    2.0957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7325    1.2684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4472    0.8555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4454    2.5084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1607    2.0993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1615    1.2726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5869    2.1062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8711    2.5135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.5917    1.2764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8752    0.8650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.0448    0.0564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8664   -0.0321    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.2042    0.7218    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.4913   -0.5552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6859   -0.3768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1326   -0.9876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3854   -1.7738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1965   -1.9457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7463   -1.3335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2988    2.5231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0157    2.1149    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.2938    3.3480    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.8786    3.1099    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   29.5535   -1.5035    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   27.4356    0.4093    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  2  0
  6 10  1  0
 11 14  1  0
  3  6  2  0
 14 15  2  0
  9  7  1  0
 15 16  1  0
  1  2  2  0
 16 17  2  0
  7  8  2  0
 17 18  1  0
  8  5  1  0
 18 19  2  0
 19 14  1  0
  9 10  1  0
  7 20  1  0
  5  4  2  0
 20 21  1  0
  4  1  1  0
 20 22  1  0
 20 23  1  0
  2  3  1  0
 19 24  1  0
  5  6  1  0
 15 25  1  0
M  END

Associated Targets(Human)

2008 (263 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYMS Tclin Thymidylate synthase (1651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM4E Tchem Lysine-specific demethylase 4D-like (40243 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EHMT2 Tchem Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (93046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TDP1 Tchem Tyrosyl-DNA phosphodiesterase 1 (345557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.16Molecular Weight (Monoisotopic): 382.0000AlogP: 5.27#Rotatable Bonds: 1
Polar Surface Area: 43.08Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 0.48CX LogP: 4.48CX LogD: 4.48
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.45Np Likeness Score: -1.48

References

1. Carosati E, Sforna G, Pippi M, Marverti G, Ligabue A, Guerrieri D, Piras S, Guaitoli G, Luciani R, Costi MP, Cruciani G..  (2010)  Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors.,  18  (22): [PMID:20951595] [10.1016/j.bmc.2010.09.065]
2. PubChem BioAssay data set,